Literature DB >> 1385204

Tonic activation of locus coeruleus neurons by systemic or intracoerulear microinjection of an irreversible acetylcholinesterase inhibitor: increased discharge rate and induction of C-fos.

M Ennis1, M T Shipley.   

Abstract

Recent studies in this laboratory have demonstrated that intramuscular injection of the irreversible acetylcholinesterase (AChE) inhibitor, soman (pinacolylmethylphosphonofluoridate), produces a rapid (1-2 h) and profound depletion (70% of control) of norepinephrine (NE) in the olfactory bulb and forebrain. NE is decreased only in convulsing animals. As NE-containing locus coeruleus (LC) neurons provide the only NE input to the olfactory bulb and the major NE innervation of the forebrain, the reduction of NE suggests that soman may cause tonic activation of LC neurons leading to rapid depletion of NE. Activation of LC may result from: (i) facilitation of cholinergic transmission in LC; (ii) soman-induced activation of excitatory inputs to LC; or (iii) generalized activation of LC neurons due to seizures. The present experiments were designed to assess these alternatives. We examined whether LC neuronal activity, c-fos expression, and AChE staining are altered after peripheral (systemic) or direct intracoerulear injection of soman in anesthetized rats. Both modes of soman administration rapidly and potently increase the spontaneous discharge rate of LC neurons. This activation was associated with a desynchronization of the electroencephalogram, but not with seizures. The discharge of LC neurons remained elevated at all postsoman intervals examined (up to 2 h) and was rapidly and completely reversed by systemic injection of the muscarinic receptor antagonist scopolamine hydrochloride, but not by the nicotinic receptor antagonist mecamylamine. Both systemic and intracoerulear soman administration completely inhibited AChE staining in LC and rapidly induced the expression of c-fos in LC neurons. These results demonstrate that soman potently and tonically activates LC neurons. This effect appears to be mediated by direct inhibition of AChE in LC leading to a rapid accumulation of ACh. Unhydrolyzed ACh tonically activates LC neurons via muscarinic receptors. Soman-induced activation of LC neurons does not require seizures. We conclude that depletion of forebrain and olfactory bulb NE after systemic administration of soman results from tonic hypercholinergic stimulation of LC.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385204     DOI: 10.1016/0014-4886(92)90033-m

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  6 in total

Review 1.  The developmental decrease in REM sleep: the role of transmitters and electrical coupling.

Authors:  Edgar Garcia-Rill; Amanda Charlesworth; David Heister; Meijun Ye; Abdallah Hayar
Journal:  Sleep       Date:  2008-05       Impact factor: 5.849

Review 2.  ARP, the cleavable C-terminal peptide of "readthrough" acetylcholinesterase, promotes neuronal development and plasticity.

Authors:  Amir Dori; Hermona Soreq
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

3.  Activation of locus coeruleus enhances the responses of olfactory bulb mitral cells to weak olfactory nerve input.

Authors:  M Jiang; E R Griff; M Ennis; L A Zimmer; M T Shipley
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

4.  Acetylcholinesterase inhibition by 1-methyl-4-phenylpyridinium ion, a bioactivated metabolite of MPTP.

Authors:  L Y Zang; H P Misra
Journal:  Mol Cell Biochem       Date:  1993-09-22       Impact factor: 3.396

5.  Inactivation of acetylcholinesterase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride.

Authors:  Lun-Yi Zang; Hara P Misra
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

6.  Locus coeruleus neurons: cessation of activity during cataplexy.

Authors:  M F Wu; S A Gulyani; E Yau; E Mignot; B Phan; J M Siegel
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.